Literature DB >> 14564300

Loss of bone marrow-derived vascular progenitor cells leads to inflammation and atherosclerosis.

Pascal J Goldschmidt-Clermont1.   

Abstract

BACKGROUND: Aging represents the most powerful risk for the development of atherosclerosis and atherosclerotic thromboembolic complications. Yet, the mechanism by which aging affects the arterial wall and its deterioration has remained essentially uncharacterized.
FINDINGS: Chronic injuries to the arterial wall contribute to the development of atherosclerosis. However, it is important to note that a complex repair system that involves both local and bone marrow-derived cells maintains arterial homeostasis and integrity. With this review, we explain how the age-dependent failure of the bone marrow to produce vascular progenitor cells responsible for such arterial repair--an inability that results from the impact of a lifetime of risk factors such as hyperlipidemia--drives atherosclerosis and its thromboembolic complications. As a consequence of such failure, the normal processes of arterial wall repair and rejuvenation are impaired. The disequilibrium that ensues between injury of the arterial wall and repair leads to atherosclerotic inflammation and consequent thromboembolic complications.
CONCLUSION: The bone marrow and derived progenitor cells represent key regulators of atherosclerosis, and progress in the prevention and treatment of atherosclerosis and its thromboembolic complications will need to take into account this new dimension for the disease process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14564300     DOI: 10.1016/j.ahj.2003.09.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  Jay and Jeanie Schottenstein prize in cardiovascular science: predicting cardiovascular illnesses for the 21(st) century, and the unpredictable...

Authors:  Pascal J Goldschmidt-Clermont
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

Review 2.  The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors:  Yagna P R Jarajapu; Maria B Grant
Journal:  Circ Res       Date:  2010-03-19       Impact factor: 17.367

Review 3.  Atherosclerosis, inflammation, genetics, and stem cells: 2012 update.

Authors:  Pascal J Goldschmidt-Clermont; Chunming Dong; David M Seo; Omaida C Velazquez
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

Review 4.  Heartache and heartbreak--the link between depression and cardiovascular disease.

Authors:  Charles B Nemeroff; Pascal J Goldschmidt-Clermont
Journal:  Nat Rev Cardiol       Date:  2012-06-26       Impact factor: 32.419

5.  Molecular evidence for arterial repair in atherosclerosis.

Authors:  Ravi Karra; Sreekanth Vemullapalli; Chunming Dong; Edward E Herderick; Xiaohua Song; Kathy Slosek; Joseph R Nevins; Mike West; Pascal J Goldschmidt-Clermont; David Seo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

6.  Will periodic intravenous injections of conditioned bone marrow cells effectively reduce atherosclerosis?

Authors:  Xiaohua Song; Qi Ma; Xialin Liu; Pearl Seo; Ed Herderick; Keith Webster; Pascal J Goldschmidt-Clermont; David Seo
Journal:  Antioxid Redox Signal       Date:  2011-09-22       Impact factor: 8.401

7.  Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.

Authors:  Si-Jin Liu; Zi-Wei Cai; Ya-Jun Liu; Mei-Yu Dong; Li-Qiu Sun; Guo-Fa Hu; Ying-Yun Wei; Wei-De Lao
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 8.  Vascular actions of estrogens: functional implications.

Authors:  Virginia M Miller; Sue P Duckles
Journal:  Pharmacol Rev       Date:  2008-06-25       Impact factor: 25.468

9.  Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with type 1 diabetes without macrovascular disease or microalbuminuria.

Authors:  L Sibal; A Aldibbiat; S C Agarwal; G Mitchell; C Oates; S Razvi; J U Weaver; J A Shaw; P D Home
Journal:  Diabetologia       Date:  2009-05-30       Impact factor: 10.122

Review 10.  Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Authors:  Nina A Mikirova; James A Jackson; Ron Hunninghake; Julian Kenyon; Kyle W H Chan; Cathy A Swindlehurst; Boris Minev; Amit N Patel; Michael P Murphy; Leonard Smith; Doru T Alexandrescu; Thomas E Ichim; Neil H Riordan
Journal:  J Transl Med       Date:  2009-12-15       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.